# v6.0

## Related releases

## Data changes
### Gene
```
ALDH1A3 Background Updated
ALDH1A3 Summary Updated
ANK1 Background Updated
ANK1 Summary Updated
APOBEC3B Background Updated
APOBEC3B Summary Updated
ATG5 Background Updated
ATG5 Summary Updated
BABAM2 Background Updated
BABAM2 Summary Updated
BCL9L Background Updated
BCL9L Summary Updated
BIRC5 Background Updated
BIRC5 Summary Updated
BRD2 Background Updated
BRD2 Summary Updated
BRD9 Background Updated
BRD9 Summary Updated
CCAR1 Background Updated
CCAR1 Summary Updated
CCNB1IP1 Background Updated
CCNB1IP1 Summary Updated
CEP43 Background Updated
CEP43 Summary Updated
CHCHD7 Background Updated
CHCHD7 Summary Updated
CILK1 Background Updated
CILK1 Summary Updated
CLIP1 Background Updated
CLIP1 Summary Updated
DICER1 Background Updated
KDSR Background Updated
KDSR Summary Updated
LASP1 Background Updated
LASP1 Summary Updated
MLF1 Background Updated
MLF1 Summary Updated
```

### Alteration
```
ALDH1A3 Amplification, Mutation Effect, Description Updated
ALDH1A3 Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
ALDH1A3 Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
ALDH1A3 Amplification Added
ALK STRN3-ALK Fusion, Mutation Effect, Description Updated
ALK STRN3-ALK Fusion, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
ALK STRN3-ALK Fusion, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
ALK STRN3-ALK Fusion Added
ALK ALK-MTUS2 Fusion, Mutation Effect, Description Updated
ALK ALK-MTUS2 Fusion, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
ALK ALK-MTUS2 Fusion, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
ALK ALK-MTUS2 Fusion Added
ALK BABAM2-ALK Fusion, Mutation Effect, Description Updated
ALK BABAM2-ALK Fusion, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
ALK BABAM2-ALK Fusion, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
ALK BABAM2-ALK Fusion Added
ANK1 Amplification, Mutation Effect, Description Updated
ANK1 Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
ANK1 Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
ANK1 Amplification Added
ANK1 Deletion, Mutation Effect, Description Updated
ANK1 Deletion, Mutation Effect, Effect Updated
	 New: Likely Loss-of-function
	 Old: 
ANK1 Deletion, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
ANK1 Deletion Added
APOBEC3B Amplification, Mutation Effect, Description Updated
APOBEC3B Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
APOBEC3B Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
APOBEC3B Amplification Added
ATG5 Deletion, Mutation Effect, Description Updated
ATG5 Deletion, Mutation Effect, Effect Updated
	 New: Likely Loss-of-function
	 Old: 
ATG5 Deletion, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
ATG5 Deletion Added
ATG5 Truncating Mutations, Mutation Effect, Description Updated
ATG5 Truncating Mutations, Mutation Effect, Effect Updated
	 New: Likely Loss-of-function
	 Old: 
ATG5 Truncating Mutations, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
ATG5 Truncating Mutations Added
BCL9L Amplification, Mutation Effect, Description Updated
BCL9L Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
BCL9L Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
BCL9L Amplification Added
BIRC5 Amplification, Mutation Effect, Description Updated
BIRC5 Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
BIRC5 Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
BIRC5 Amplification Added
BRCA1 T1196I, Mutation Effect, Description Updated
BRCA1 T1196I, Mutation Effect, Effect Updated
	 New: Inconclusive
	 Old: 
BRCA1 T1196I, Mutation Effect, Oncogenic Updated
	 New: Inconclusive
	 Old: 
BRCA1 T1196I Added
BRD2 Amplification, Mutation Effect, Description Updated
BRD2 Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
BRD2 Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
BRD2 Amplification Added
BRD9 Amplification, Mutation Effect, Description Updated
BRD9 Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
BRD9 Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
BRD9 Amplification Added
CARD11 F115I, Mutation Effect, Description Updated
CARD11 F115I, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CARD11 F115I, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CARD11 F115I Promoted
CARD11 E134G, Mutation Effect, Description Updated
CARD11 K215del, Mutation Effect, Description Updated
CARD11 K215del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CARD11 K215del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CARD11 K215del Added
CARD11 K344del, Mutation Effect, Description Updated
CARD11 K344del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CARD11 K344del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CARD11 K344del Added
CARD11 H234_K238delinsL, Mutation Effect, Description Updated
CARD11 H234_K238delinsL, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CARD11 H234_K238delinsL, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CARD11 H234_K238delinsL Added
CARD11 T117P, Mutation Effect, Description Updated
CARD11 T117P, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CARD11 T117P, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CARD11 T117P Added
CARD11 G126R, Mutation Effect, Description Updated
CARD11 G126R, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CARD11 G126R, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CARD11 G126R Added
CARD11 F130C, Mutation Effect, Description Updated
CARD11 F130C, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CARD11 F130C, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CARD11 F130C Added
CARD11 C49E, Mutation Effect, Description Updated
CARD11 C49E, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CARD11 C49E, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CARD11 C49E Added
CARD11 C49F, Mutation Effect, Description Updated
CARD11 C49F, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CARD11 C49F, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CARD11 C49F Added
CARD11 C49N, Mutation Effect, Description Updated
CARD11 C49N, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CARD11 C49N, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CARD11 C49N Added
CCAR1 Deletion, Mutation Effect, Description Updated
CCAR1 Deletion, Mutation Effect, Effect Updated
	 New: Likely Loss-of-function
	 Old: 
CCAR1 Deletion, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CCAR1 Deletion Added
CCAR1 Truncating Mutations, Mutation Effect, Description Updated
CCAR1 Truncating Mutations, Mutation Effect, Effect Updated
	 New: Likely Loss-of-function
	 Old: 
CCAR1 Truncating Mutations, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CCAR1 Truncating Mutations Added
CEP43 Amplification, Mutation Effect, Description Updated
CEP43 Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CEP43 Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CEP43 Amplification Added
CILK1 Amplification, Mutation Effect, Description Updated
CILK1 Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CILK1 Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CILK1 Amplification Added
CILK1 A615T, Mutation Effect, Description Updated
CILK1 A615T, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CILK1 A615T, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CILK1 A615T Added
CILK1 R632*, Mutation Effect, Description Updated
CILK1 R632*, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
CILK1 R632*, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
CILK1 R632* Added
CILK1 K220E, Mutation Effect, Description Updated
CILK1 K220E, Mutation Effect, Effect Updated
	 New: Likely Loss-of-function
	 Old: 
CILK1 K220E, Mutation Effect, Oncogenic Updated
	 New: Inconclusive
	 Old: 
CILK1 K220E Added
CILK1 I102L, Mutation Effect, Description Updated
CILK1 I102L, Mutation Effect, Effect Updated
	 New: Likely Loss-of-function
	 Old: 
CILK1 I102L, Mutation Effect, Oncogenic Updated
	 New: Inconclusive
	 Old: 
CILK1 I102L Added
CILK1 K305T, Mutation Effect, Description Updated
CILK1 K305T, Mutation Effect, Effect Updated
	 New: Likely Loss-of-function
	 Old: 
CILK1 K305T, Mutation Effect, Oncogenic Updated
	 New: Inconclusive
	 Old: 
CILK1 K305T Added
CILK1 V320I, Mutation Effect, Description Updated
CILK1 V320I, Mutation Effect, Effect Updated
	 New: Likely Loss-of-function
	 Old: 
CILK1 V320I, Mutation Effect, Oncogenic Updated
	 New: Inconclusive
	 Old: 
CILK1 V320I Added
EGFR V834L, Mutation Effect, Description Updated
ERBB2 Q711H, Mutation Effect, Description Updated
ERBB2 E717K, Mutation Effect, Description Updated
ERBB2 E717K, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: Inconclusive
ERBB2 E717K, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: Resistance
ESR1 D538, E380, Y537, L536, L469V, S463P, G442R, F461V (Level 1 Elascetrant) Name Changed
	 New: D538, E380, Y537, L536, L469V, S463P, G442R, F461V (Level 1 Elascetrant)
	 Old: D538, E380, Y537, L536, L469V, S463P, G422R, F461V (Level 1 Elacestrant)
EZH2 R213H, Mutation Effect, Description Updated
EZH2 R213H, Mutation Effect, Effect Updated
	 New: Inconclusive
	 Old: 
EZH2 R213H, Mutation Effect, Oncogenic Updated
	 New: Inconclusive
	 Old: 
EZH2 R213H Added
FGFR1 CEP43-FGFR1 Fusion Name Changed
	 New: CEP43-FGFR1 Fusion
	 Old: FGFR1OP-FGFR1 Fusion (FOP-FGFR1 Fusion)
FGFR1 CEP43-FGFR1 Fusion, Mutation Effect, Description Updated
KRAS A18D, Mutation Effect, Description Updated
LASP1 Amplification, Mutation Effect, Description Updated
LASP1 Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
LASP1 Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
LASP1 Amplification Added
LYN Y508*, Mutation Effect, Description Updated
LYN Y508*, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
LYN Y508*, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
LYN Y508* Added
LYN Q507*, Mutation Effect, Description Updated
LYN Q507*, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
LYN Q507*, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
LYN Q507* Added
LYN Y508F, Mutation Effect, Description Updated
LYN Y508F, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
LYN Y508F, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
LYN Y508F Added
LYN Y508H, Mutation Effect, Description Updated
LYN Y508H, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
LYN Y508H, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
LYN Y508H Added
LYN D189Y, Mutation Effect, Description Updated
LYN D189Y, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
LYN D189Y, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
LYN D189Y Added
LYN E159K, Mutation Effect, Description Updated
LYN E159K, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
LYN E159K, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
LYN E159K Added
LYN K209N, Mutation Effect, Description Updated
LYN K209N, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
LYN K209N, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
LYN K209N Added
LYN G418R, Mutation Effect, Description Updated
LYN G418R, Mutation Effect, Effect Updated
	 New: Likely Neutral
	 Old: 
LYN G418R, Mutation Effect, Oncogenic Updated
	 New: Likely Neutral
	 Old: 
LYN G418R Added
LYN Amplification, Mutation Effect, Description Updated
LYN Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
LYN Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
LYN Amplification Added
MLF1 Amplification, Mutation Effect, Description Updated
MLF1 Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
MLF1 Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
MLF1 Amplification Added
NPM1 Deletion, Mutation Effect, Description Updated
NPM1 NPM1-MLF1 Fusion, Mutation Effect, Description Updated
PHF6 R274Q, Mutation Effect, Description Updated
PHF6 R274E, Mutation Effect, Description Updated
PHF6 R274E, Mutation Effect, Effect Updated
	 New: Inconclusive
	 Old: Likely Loss-of-function
PHF6 R274E, Mutation Effect, Oncogenic Updated
	 New: Inconclusive
	 Old: Likely
RET CEP43-RET Fusion, Mutation Effect, Description Updated
RET CEP43-RET Fusion, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old: 
RET CEP43-RET Fusion, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old: 
RET CEP43-RET Fusion Added
ROS1 TFG-ROS1 Fusion, Mutation Effect, Description Updated
UBTF 402_453ins [Internal Tandem Duplication], Mutation Effect, Description Updated
```

### Evidence
```
ALDH1A3 Gene Type, Oncogene Updated
ANK1 Gene Type, Oncogene Updated
ANK1 Gene Type, Tumor Suppressor Updated
APOBEC3B Gene Type, Oncogene Updated
ATG5 Gene Type, Tumor Suppressor Updated
BABAM2 Gene Type, Insufficient Evidence Updated
BCL9L Gene Type, Oncogene Updated
BIRC5 Gene Type, Oncogene Updated
BRCA2 Oncogenic Mutations, Prostate Cancer, Niraparib + Abiraterone Acetate + Prednisone, Description Updated
BRD2 Gene Type, Oncogene Updated
BRD9 Gene Type, Oncogene Updated
CCAR1 Gene Type, Tumor Suppressor Updated
CCNB1IP1 Gene Type, Insufficient Evidence Updated
CEP43 Gene Type, Oncogene Updated
CHCHD7 Gene Type, Insufficient Evidence Updated
CILK1 Gene Type, Oncogene Updated
CLIP1 Gene Type, Oncogene Updated
ERBB2 Oncogenic Mutations, Non-Small Cell Lung Cancer, Sevabertinib, Description Updated
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations), Non-Small Cell Lung Cancer, Zongertinib, Description Updated
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations), Other Tumor Types, Summary Updated
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations), Non-Small Cell Lung Cancer {excluding Lung Squamous Cell Carcinoma}, Summary Updated
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations), Non-Small Cell Lung Cancer {excluding Lung Squamous Cell Carcinoma}, Sevabertinib, Description Updated
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations), Non-Small Cell Lung Cancer {excluding Lung Squamous Cell Carcinoma} Name Changed
	 New: Non-Small Cell Lung Cancer {excluding Lung Squamous Cell Carcinoma}
	 Old: 
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations), Non-Small Cell Lung Cancer {excluding Lung Squamous Cell Carcinoma}, Sevabertinib, FDA Level Updated
	 New: Fda2
	 Old: no
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations), Non-Small Cell Lung Cancer {excluding Lung Squamous Cell Carcinoma}, Sevabertinib, Level Updated
	 New: 1
	 Old: 
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations), Non-Small Cell Lung Cancer {excluding Lung Squamous Cell Carcinoma}, Sevabertinib, Propagation to Other Liquid Tumor Types Updated
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations), Non-Small Cell Lung Cancer {excluding Lung Squamous Cell Carcinoma}, Sevabertinib, Propagation to Other Solid Tumor Types Updated
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations), Non-Small Cell Lung Cancer {excluding Lung Squamous Cell Carcinoma}, Sevabertinib 1 Added
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations), Lung Squamous Cell Carcinoma, Summary Updated
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations), Lung Squamous Cell Carcinoma Added
FLT3 D835, I836, I867S, R834Q, N676K, D839G, N841I, Y842C, Acute Myeloid Leukemia, Summary Updated
FLT3 D835, I836, I867S, R834Q, N676K, D839G, N841I, Y842C, Other Liquid Tumor Types, Summary Updated
KDSR Gene Type, Insufficient Evidence Updated
LASP1 Gene Type, Oncogene Updated
MLF1 Gene Type, Oncogene Updated
MLF1 Gene Type, Tumor Suppressor Updated
NRAS Oncogenic Mutations, Juvenile Myelomonocytic Leukemia, Diagnostic Summary Updated
ROS1 Fusions, Non-Small Cell Lung Cancer, Taletrectinib, Additional Information Updated
```

